0001209191-21-014743.txt : 20210226 0001209191-21-014743.hdr.sgml : 20210226 20210226162032 ACCESSION NUMBER: 0001209191-21-014743 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 21689155 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Patient Officer Common Stock 2021-02-24 4 F 0 2946 217.57 D 43719 D Common Stock 2021-02-25 4 S 0 922 211.56 D 42797 D Common Stock 2021-02-25 4 S 0 1460 213.30 D 41337 D Common Stock 2021-02-25 4 S 0 668 214.19 D 40669 D Common Stock 2021-02-25 4 S 0 336 215.56 D 40333 D Common Stock 2021-02-25 4 S 0 200 216.62 D 40133 D Common Stock 882 I 401(k) Common Stock 7368 I Held in trust Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $211.56 (range $211.06 to $211.87). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $213.30 (range $212.93 to $213.88). Open market sales reported on this line occurred at a weighted average price of $214.19 (range $213.94 to $214.78). Open market sales reported on this line occurred at a weighted average price of $215.56 (range $215.12 to $215.85). /s/ Sabrina Yohai, Attorney-in-Fact 2021-02-26